Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

Magali Lemaitre (1) , Julien Kirchgesner (1, 2, 3) , Annie Rudnichi (1) , Fabrice Carrat (3, 2) , Mahmoud Zureik (1) , Franck Carbonnel (4, 5) , Rosemary Dray-Spira (1)

1 ANSM - Agence nationale de sécurité du médicament et des produits de santé [Saint-Denis]
2 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
3 CHU Saint-Antoine [AP-HP]
4 Department of Gastroenterology
5 Université Paris Sud (Paris 11)

Domaines: Sciences du Vivant [q-bio]

Magali Lemaitre, Julien Kirchgesner, Annie Rudnichi, Fabrice Carrat, Mahmoud Zureik, et al.. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease. Journal of the American Medical Association, 2017, 318 (17), pp.1679. ⟨10.1001/jama.2017.16071⟩. ⟨hal-03703936⟩